Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration

John M. Lawton, Lars T. Conway, John T. Crosson, Charles L. Smith, Paul A. Abraham

Research output: Contribution to journalArticlepeer-review

76 Scopus citations


A single 45-g dose of intravenous ascorbic acid, a metabolic precursor of oxalate, was administered to a patient as adjuvant therapy for primary amyloidosis and the nephrotic syndrome. Acute oliguric renal failure occurred. Postmortem histopathologic examination of renal tissue revealed extensive intratubular deposition of crystalline material, which was confirmed as calcium oxalate by a microincineration technique. There were no extrarenal deposits of calcium oxalate. Plasma oxalate and ascorbic acid concentrations were increased. We conclude that therapy with high-dose ascorbic acid is a potential cause of oxalate nephropathy.

Original languageEnglish (US)
Pages (from-to)950-951
Number of pages2
JournalArchives of Internal Medicine
Issue number5
StatePublished - May 1985


Dive into the research topics of 'Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration'. Together they form a unique fingerprint.

Cite this